Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Robert Diasio MD

Robert B. Diasio MD

William J. and Charles H. Mayo Professor; Director Emeritus, Mayo Clinic Cancer Center; Professor of Molecular Pharmacology & Experimental Therapeutics and Oncology; Consultant, College of Medicine, Rochester, Minnesota

Dr. Diasio received his medical degree from Yale University School of medicine, followed by residency training in internal medicine at Strong Memorial Hospital in Rochester, NY, and then oncology and clinical pharmacology training at the National Cancer Institute. After 4 decades in academic oncology and pharmacology, he recently became Director and Professor Emeritus, in the Mayo Clinic Cancer Center and the Departments of Molecular Pharmacology & Experimental Therapeutics, and Oncology at Mayo Clinic. Dr. Diasio has published extensively with chapters in major textbooks as well as original research manuscripts. He has had a long-time interest in 5-Fluorouracil pharmacology and helped characterize the pharmacogenetic syndrome of dihydropyrimidine dehydrogenase (DPD) deficiency.

Disclosures

No disclosures reported.